The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients

Oncotarget
Han Sol ChoiEun-Suk Kang

Abstract

The prognostic effects of tumor infiltrating lymphocytes (TILs), especially regulatory T cells (Tregs) and myeloid derived suppressing cells (MDSCs) are inconclusive in gastric cancers. We investigated the frequencies of TILs including CD8+ T cells, CD45+CD4+CD25± FOXP3+ Tregs, CD45+CD11b+ CD14+ HLA-DR- MDSCs in 28 gastric cancer tissues by using multicolor flow cytometry. In gastric cancer tissue, the percentage of Tregs among the CD4+ T cell subset was substantially increased compared to that of Tregs among peripheral blood CD4+ T cells from the controls. High frequency of CD8+ T cells among CD3+ T cells correlated with increased overall survival (OS) (p = 0.005). High frequency of Tregs among CD4+ T cells correlated with increased OS (p < 0.001), and disease-free survival (DFS) (p = 0.039) and was an independent prognostic factor in OS (Hazard ratio: 0.047; 95% confidence interval, 0.006-0.372; p = 0.004). High frequency of MDSCs among total examined cells correlated with decreased OS (p = 0.027) and was an independent prognostic factor in OS (Hazard ratio 8.601; 95% confidence interval, 1.240-59.678; p = 0.029). We have demonstrated that high levels of Tregs among tumor-infiltrating CD4+ T cells were favorable, but an incre...Continue Reading

References

Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Feb 19, 2003·Journal of Clinical Epidemiology·Jon R Kelley, John M Duggan
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Jan 9, 2004·Advances in Immunology·Shohei HoriShimon Sakaguchi
Jul 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Svetlana KondratievMurray B Resnick
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L CampDavid L Rimm
Mar 23, 2005·Immunity·Jason D FontenotAlexander Y Rudensky
Dec 6, 2005·Cancer Immunology, Immunotherapy : CII·Koji KonoHideki Fujii
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Mar 25, 2006·Nature Reviews. Immunology·Weiping Zou
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Padmanee SharmaEiichi Sato
May 4, 2007·The Journal of Clinical Investigation·Tyler J Curiel
Jul 12, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giuseppe PerroneFrancesco Graziano
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Suzanne Ostrand-Rosenberg, Pratima Sinha
Feb 10, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Srinivas NagarajDmitry I Gabrilovich
Apr 24, 2010·Cancer Immunology, Immunotherapy : CII·Suzanne Ostrand-Rosenberg
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernhard MlecnikJérôme Galon
Jun 7, 2011·Cancer Immunology, Immunotherapy : CII·Sylvain LadoireFrançois Ghiringhelli
Dec 14, 2011·Journal of Hematology & Oncology·Jing Wang, Xiao-Yan Ke
Mar 16, 2012·Nature Reviews. Cancer·Wolf Herman FridmanJérôme Galon
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Apr 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ronald J deLeeuwBrad H Nelson
Dec 19, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Linda WangKhoon Lin Ling
Oct 9, 2013·Cancer Immunology, Immunotherapy : CII·Dmitriy W Gutkin, Michael R Shurin

❮ Previous
Next ❯

Citations

Jan 10, 2018·Genes·Bruno R B PiresEliana Abdelhay
Oct 24, 2017·Nature Reviews. Cancer·Dipti VijayanMark J Smyth
Aug 16, 2017·World Journal of Gastrointestinal Oncology·Byung Woog KangAn Na Seo
Dec 8, 2017·Cancer Cell International·Long YuanQuanli Gao
Jan 6, 2018·Journal of Gastric Cancer·Seungho LeeHyoung-Il Kim
Oct 19, 2019·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Abhineet UppalAnton J Bilchik
Mar 19, 2020·Cancers·Nada ChaoulFrancesco Dituri
Apr 14, 2018·Pathogens·Geok Wee TanArjan Diepstra
Feb 6, 2019·Frontiers in Immunology·Yu Du, Yongchang Wei
Oct 31, 2019·Journal of Oncology·Lucía Figueroa-ProttiWarner Alpízar-Alpízar
Apr 24, 2018·BioMed Research International·Ming WeiYing Yin
Sep 1, 2018·World Journal of Gastroenterology : WJG·Daniela Cornelia LazărAdrian Goldiș
Jun 2, 2018·Cancer Immunology, Immunotherapy : CII·Yijun LiuHong Qin
Nov 6, 2018·Archivum Immunologiae Et Therapiae Experimentalis·Amin Pastaki KhoshbinNima Rezaei
May 29, 2021·Seminars in Cancer Biology·Stephanie LabaShoba Amarnath

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

Tile
R
SPSS
FACS DIVA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.